Harvard Health Blog

Baloxavir (Xofluza): A new antiviral drug for the flu

By: Daniel Kuritzkes, MD, Contributor A new drug for the treatment of influenza was approved by the US Food and Drug Administration (FDA) in October 2018, just in time for the 201819 flu season. Baloxavir marboxil (Xofluza) works against the two types of influenza virus that cause disease in humans, influenza A and B. …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In